Related Experiment Video

Updated: Aug 16, 2026

Production and Purification of Non Replicative Canine Adenovirus Type 2 Derived Vectors
14:55

Production and Purification of Non Replicative Canine Adenovirus Type 2 Derived Vectors

Published on: December 3, 2013

Potentials and limitations of adenovirus-p53 gene therapy for brain tumors

Y K Hong1, Y A Joe, Y J Yang

  • 1Department of Neurosurgery, The Catholic University of Korea, Seoul. hongyk@cmc.cuk.ac.kr

Journal of Korean Medical Science
|July 15, 2000
PubMed

Insights

Recombinant adenovirus carrying p53 (Ad5CMV-p53) showed potent anti-glioma effects in specific cell lines but faced challenges. Gene delivery and adenoviral toxicity limit its use in malignant glioma gene therapy.

Area of Science:

  • Oncology
  • Gene Therapy
  • Molecular Biology

Background:

  • Malignant gliomas are aggressive brain tumors with limited treatment options.
  • The p53 tumor suppressor gene plays a critical role in cancer, making it a target for gene therapy.
  • Recombinant adenoviruses are commonly used vectors for gene delivery in cancer research.

Purpose of the Study:

  • To evaluate the antineoplastic potential of recombinant adenovirus containing wild-type p53 cDNA (Ad5CMV-p53) against malignant gliomas.
  • To assess the gene transfer efficiency and therapeutic efficacy of Ad5CMV-p53 in various glioma cell lines.
  • To investigate the toxicity of Ad5CMV-p53 in the brain.

Main Methods:

  • Gene transfer efficiency was assessed using X-gal staining and Western blotting across human and rat glioma cell lines with varying p53 statuses.
  • In vitro growth inhibition assays were performed at different multiplicities of infection (MOI).
  • In vivo studies involved ex vivo transduction of cells and direct tumor injection in rodent models, alongside histopathologic examination for toxicity.

Main Results:

  • Gene transfer efficiency varied significantly (10-99%) depending on the cell line and MOI.
  • A drastic growth inhibitory effect (>90%) was observed in U-251 cells (mutant p53), while other cell lines showed moderate to minimal responses.
  • Ex vivo transduction suppressed in vivo tumor formation, but direct tumor injection in mice did not yield significant tumor suppression or survival benefit. Adenoviral toxicity (inflammatory reactions) was noted in rat brains at high MOI.

Conclusions:

  • The p53 status of glioma cells, variable gene delivery efficiency, and adenoviral toxicity are critical factors influencing the efficacy of Ad5CMV-p53 gene therapy.
  • Further research is needed to overcome these limitations for successful adenovirus-mediated p53 gene therapy in malignant gliomas.
  • Targeting specific cellular subpopulations and optimizing delivery methods are crucial for future therapeutic development.

More Related Videos

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System11:06

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System

Published on: July 30, 2018

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting08:14

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting

Published on: October 26, 2018

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.